» Articles » PMID: 11348870

Vascular Injury Induces Posttranscriptional Regulation of the Id3 Gene: Cloning of a Novel Id3 Isoform Expressed During Vascular Lesion Formation in Rat and Human Atherosclerosis

Overview
Date 2001 May 23
PMID 11348870
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular mechanisms that regulate the proliferation of smooth muscle cells (SMCs) of the vasculature in response to injury are poorly understood. Members of the inhibitor of DNA binding (Id) class of helix-loop-helix transcription factors are known to regulate the growth of a variety of cell types; however, the expression of the various Id genes in SMCs and in vascular lesions has not been examined. In the present study, the yeast 2-hybrid system was used to clone Id genes from a cultured rat aortic SMC library. By use of ubiquitous E proteins as bait, Id3 and a novel isoform of Id3 (Id3a) were cloned. Id3a is the product of alternative splicing of the Id3 gene, resulting in inclusion of a 115-bp "coding intron," which encodes a unique 29-amino acid carboxyl terminus for the Id3a protein. Unlike Id3, Id3a mRNA was not detected in the normal rat carotid artery. However, after balloon injury, Id3a was abundantly expressed throughout the neointimal layer. In addition, mRNA of the human homologue of Id3a (Id3L) was detected in human carotid atherosclerotic plaques. Adenovirus-mediated overexpression of these Id3 isoforms in cultured rat aortic SMCs revealed that infection of SMCs with an adenovirus overexpressing Id3a (in contrast to Id3) resulted in a significant decrease in cell number versus AdLacZ-infected cells. DNA fragmentation analysis suggested that this decrease in SMC viability was due to increased apoptotic activity in cells infected with adenovirus overexpressing Id3a. These results provide evidence that alternative splicing of the Id3 gene may represent an important mechanism by which neointimal SMC growth is attenuated during vascular lesion formation.

Citing Articles

Pathophysiological Features of Remodeling in Vascular Diseases: Impact of Inhibitor of DNA-Binding/Differentiation-3 and Estrogenic Endocrine Disruptors.

Avecilla V, Doke M, Appunni S, Rubens M, Ramamoorthy V, Das J Med Sci (Basel). 2025; 13(1.

PMID: 39846697 PMC: 11755649. DOI: 10.3390/medsci13010002.


Regulation of Transcription Factors by Reactive Oxygen Species and Nitric Oxide in Vascular Physiology and Pathology.

Kohlgruber S, Upadhye A, Dyballa-Rukes N, McNamara C, Altschmied J Antioxid Redox Signal. 2016; 26(13):679-699.

PMID: 27841660 PMC: 5421514. DOI: 10.1089/ars.2016.6946.


Microvascular lesions by estrogen-induced ID3: its implications in cerebral and cardiorenal vascular disease.

Das J, Felty Q J Mol Neurosci. 2014; 55(3):618-31.

PMID: 25129100 PMC: 4320014. DOI: 10.1007/s12031-014-0401-9.


PCB153-induced overexpression of ID3 contributes to the development of microvascular lesions.

Das J, Felty Q PLoS One. 2014; 9(8):e104159.

PMID: 25090023 PMC: 4121297. DOI: 10.1371/journal.pone.0104159.


Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic β-cells.

Lee S, Hao E, Levine F, Itkin-Ansari P Islets. 2011; 3(6):358-66.

PMID: 21964314 PMC: 3329516. DOI: 10.4161/isl.3.6.17923.